Characteristics of the level of virus-neutralizing antibodies to SARS-CoV-2 in patients with hiv after COVID-19

1. Alrubayyi A., Gea-Mallorquí E., Touizer E. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV // bioRxiv: the preprint server for biology, 2021.02.15.431215. https://doi.org/10.1101/2021.02.15.431215

2. Liu W.D., Hung C.C., Wang J.T. Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 // Journal of the Formosan Medical Association = Taiwan yi zhi. 2021. Vol. 120, No. 12. Р. 2186–2190. https://doi.org/10.1016/j.jfma.2021.04.010.

3. Macías J., Fernández-Fuertes M., Oliver N. Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2022. Vol. 28, No. 5. Р. 755–756. https://doi.org/10.1016/j.cmi.2022.01.028.